Report #2860230

Received Sep 22, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: Age unknown
State: VA
Recovered: Unknown
Vaccinated: Aug 22, 2024
Onset: Aug 22, 2024
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
HEP	HEP B (HEPLISAV-B)	DYNAVAX TECHNOLOGIES CORPORATION	1	943186	IM

Symptoms (1)

Incomplete course of vaccination

Symptom narrative

Patient Received First Dose of HEPLISAV-B One Year Ago, Has Not Received The Second Dose; Initial report received on 27-Aug-2025. A pharmacy technician reported that a 26-year-old female received the first dose of HEPLISAV-B (hepatitis B vaccine) for hepatitis B immunization one year ago but never received the second dose. No medical history or concomitant medications were reported. The patient had no known drug allergies. On 22-Aug-2024, the patient received dose 1 of a hepatitis B vaccine HEPLISAV-B (lot number 943186, expiration date 30-Nov-2025, and NDC number 43528-0003-05; site not available) intramuscularly. At the time of reporting, the patient had not received the second dose of HEPLISAV-B yet. No other information was available. Company Comment: The company assessed the event as non-serious.; Sender's Comments: The company assessed the event as non-serious.